| 1 |
35362022 | Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation. | 2022 Apr 29 |
2 |
| 2 |
34213307 | Glucosylceramide Associated with Gaucher Disease Forms Amyloid-like Twisted Ribbon Fibrils That Induce α-Synuclein Aggregation. | 2021 Jul 2 |
1 |
| 3 |
34811369 | Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI. | 2021 Nov 22 |
1 |
| 4 |
30315684 | Neurological effects of glucocerebrosidase gene mutations. | 2019 Mar |
1 |
| 5 |
28847804 | Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease. | 2017 Oct 4 |
1 |
| 6 |
25933391 | Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. | 2015 |
1 |
| 7 |
23118351 | Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds. | 2013 Feb 15 |
2 |
| 8 |
22337770 | Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, β-glucocerebrosidase. | 2012 Apr |
1 |
| 9 |
21221911 | The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approaches. | 2010 Dec |
1 |
| 10 |
19374450 | Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. | 2009 Jun 9 |
2 |